Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive
Summary of opinion: Vectra 3D, 10/09/2026 Positive
Summary of opinion: Vectormune HVT-AIV, 10/09/2026 Positive
Summary of opinion: Felpreva, 10/09/2026 Positive
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 September 2026
ICH M12 on drug interaction studies - Scientific guideline
Draft guideline on the investigation of interactions in the gastrointestinal tract
HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 November 2026 to 13 November 2026